StockData
PTC Therapeutics, Inc. logo

PTC Therapeutics, Inc. (PTCT) stock

PTCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 5/3028% above fair value
$60.36−0.61 (-1.00%)

Close on Nov 17, 2026Market cap $5.04BP/E –Yield –

PTC Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

PTC Therapeutics's market cap was $5.41B on Nov 11, 2026, against $6.87B a year earlier. Over the last 5 years it ranged from $1.41B to $6.87B, with a median of $3.30B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.41B-10.9%
2025Dec 31, 2025$6.07B+74.8%
2024Dec 31, 2024$3.47B+67.0%
2023Dec 29, 2023$2.08B-24.2%
2022Dec 30, 2022$2.74B-2.6%
2021Dec 31, 2021$2.81B-32.0%
2020Dec 31, 2020$4.14B+39.9%
2019Dec 31, 2019$2.96B+70.9%
2018Dec 31, 2018$1.73B+150.3%
2017Dec 29, 2017$691.60M+85.5%
2016Dec 30, 2016$372.75M-66.1%
2015Dec 31, 2015$1.10B-27.7%
2014Dec 31, 2014$1.52B+276.5%
2013Dec 31, 2013$403.94M–

More PTC Therapeutics figures

See a number that looks wrong?